Developer of anti-idiopathic pulmonary fibrosis drug created for the treatment of influenza infection, solid tumors and wound healing. The company's activities are engaged in the research, development and licensing of small molecule antioxidant SOD mimetics and peptide analogues for treatment of idiopathic pulmonary fibrosis, influenza infection, wound healing and solid tumors
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Out of Business | 22-Mar-2020 | Completed | Out of Business | |||
2. Angel (individual) | 19-Nov-2015 | 00000 | Completed | Startup | ||
1. Grant | 11-Mar-2014 | Completed | Startup |
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20170065663-A1 | Substance and method for treating influenza | Abandoned | 02-May-2014 | 0000000000 |